High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2026

What Is the Future of Personalized Medicine? A Review of Tyranny of the Gene by James Tabery.

Perspectives in biology and medicine·2026

T cell dysfunction associated with repeated CAR-T cell manufacturing failure following prolonged bispecific antibody exposure: a case report.

Leukemia research reports·2026

Home-Based Transcranial Direct Current Stimulation for Depression: From Feasibility to Clinical Implementation.

Neuropsychiatric disease and treatment·2026

Engineered Inflammation-Triggering Macrophages (MacTrigger) Synergize Anti-CD47 Immunotherapy While Sparing Normal Tissues.

Biological & pharmaceutical bulletin·2026

Synthesis, Preclinical Evaluation, and Clinical Application of the FAPI-Dimer Based on the LARM Platform.

Advanced healthcare materials·2026

Related Experiment Videos

High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement

Related Concept Videos

Multiple myeloma treatment at relapse after autologous stem cell transplantation: A practical analysis.

Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution.

Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remission.

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial.

Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

[How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: an SFGM-TC report on pre-transplant positive pregnancy test and monoclonal gammapathy].

DMT1 Facilitates Heme-iron Absorption in Rats and Mice.

New FDA-Approved Treg Therapy to Reduce Chronic GVHD After Allogeneic HSCT.

Pembrolizumab-GVD in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter phase 2 trial.

Enhanced factor VIII activation accelerates thrombin generation and hemostatic potency in mice.

--Paneth cell niche function is critical for intestinal stem cells in radiation injury but dispensable in GVHD.

Inhibition of mitochondrial permeability transition selectively suppresses thrombogenic platelet procoagulant activity.

Emerging therapies and translational tools for drug development in systemic amyloidosis: insights from the International Society of Amyloidosis Scientific Workshop.

What Is the Future of Personalized Medicine? A Review of Tyranny of the Gene by James Tabery.

T cell dysfunction associated with repeated CAR-T cell manufacturing failure following prolonged bispecific antibody exposure: a case report.

Home-Based Transcranial Direct Current Stimulation for Depression: From Feasibility to Clinical Implementation.

Engineered Inflammation-Triggering Macrophages (MacTrigger) Synergize Anti-CD47 Immunotherapy While Sparing Normal Tissues.

Synthesis, Preclinical Evaluation, and Clinical Application of the FAPI-Dimer Based on the LARM Platform.

Related Experiment Videos

High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement

Related Concept Videos

Related Articles